Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
about
Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10The cytomegalovirus homolog of interleukin-10 requires phosphatidylinositol 3-kinase activity for inhibition of cytokine synthesis in monocytesCell Surface Expression of Major Histocompatibility Complex Class I Molecules Is Reduced in Hepatitis C Virus Subgenomic Replicon-Expressing CellsAntigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells.Inhibition of human cytomegalovirus immediate-early gene expression by cyclin A2-dependent kinase activityHuman cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responsesThe Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradationTwo novel human cytomegalovirus NK cell evasion functions target MICA for lysosomal degradationEquus caballus major histocompatibility complex class I is an entry receptor for equine herpesvirus type 1Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.Varicella-zoster virus immune evasion.A comparison of viral immune escape strategies targeting the MHC class I assembly pathway.Cytomegaloviral control of MHC class I function in the mouse.Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers.Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses.The pathogenicity of cytomegalovirus.Quantitative temporal viromics: an approach to investigate host-pathogen interactionRhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response.Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes.The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells.Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirusThymic tolerance to only one viral protein reduces lymphocytic choriomeningitis virus-induced immunopathology and increases survival in perforin-deficient mice.Dominance of virus over host factors in cross-species activation of human cytomegalovirus early gene expression.Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection.Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner.Implication of gammadelta T cells in the human immune response to cytomegalovirusA human herpesvirus 7 glycoprotein, U21, diverts major histocompatibility complex class I molecules to lysosomesA mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surfaceThe transmembrane segment of a tail-anchored protein determines its degradative fate through dislocation from the endoplasmic reticulum.Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replicationControl of MHC class I traffic from the endoplasmic reticulum by cellular chaperones and viral anti-chaperones.The MHC class I antigen presentation pathway: strategies for viral immune evasion.Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation.Insight into the mechanism of human herpesvirus 7 U21-mediated diversion of class I MHC molecules to lysosomes.Human cytomegalovirus protein pp71 disrupts major histocompatibility complex class I cell surface expression.The human cytomegalovirus US8 glycoprotein binds to major histocompatibility complex class I products.A recombinant rhesus cytomegalovirus expressing enhanced green fluorescent protein retains the wild-type phenotype and pathogenicity in fetal macaques.
P2860
Q24540441-13DD45B9-E6F1-42ED-AEAE-4C632B2168E4Q24675696-BC98D76A-E4EB-43B8-880B-954E2F34F3B4Q27485758-46EFB637-C85E-4B28-949C-98FEDADD903EQ27632371-67EE20F0-F01A-486C-8AF7-078269C087CFQ28363307-0F3F7906-37D9-45E6-9EF4-05540E0F907BQ30422258-61B6A9A7-7701-4DC6-A138-D5CAD6E7DC98Q33358676-722BF50A-168B-4440-9DA0-DCF332779014Q33396983-BDBE9FDD-00B5-416F-AEB1-FE2A5AB0997BQ33553680-6F101B6F-75F5-4C2D-88FF-567AFB46F129Q33627329-B366E017-67D7-4586-A572-F5686A5C3F94Q33652150-F7D60EFD-CB83-46B7-B8FB-0888DBE3A388Q33683365-4C040B37-504A-4AD8-8D83-6AAE7401285AQ33683373-680A644E-6D99-4D90-9D2F-33976B3BDD27Q33683381-5BDCCABB-AD88-4A23-9F5E-768ADC5DB79FQ33683386-29187DFF-D9E8-4D07-9164-69E5D5F437D6Q33683408-64639A1E-4ADA-4165-AEC2-226AEE9557F4Q33697113-691F815E-A811-4A48-BC0F-9FEBF7C093FFQ33722378-E495E8A6-09C8-4F94-9354-CFC798E2CD52Q33755053-6EC33898-A67B-4788-A532-D96DF69036F4Q33782029-CBD3A93C-6060-47A3-9A6B-59A4DE777E44Q33803064-8188B3E2-4117-4D8D-A06A-EE82D17F2BC4Q33804205-61BF071F-A12F-4E5D-B673-BC125D08C199Q33809143-43100E94-7F74-4D05-8211-22B7788EF492Q33810440-F69C92FD-5DB1-4326-8374-6ADC83C24A17Q33815802-F6941341-8C88-4756-A6A6-B2957AC80D4FQ33834411-5EF196DE-0093-48DC-8A16-26AFD6C3CC87Q33847137-8C1CC3B7-3B76-4EA4-AF1D-F252409CD196Q33851857-B00E3A20-EB61-436A-8561-EF8ADA338501Q33854964-B171EFF5-57DD-4E11-968F-A2E6CB7DD01FQ33870438-33400867-E7E6-43FF-9742-CEB83D92896EQ33886108-353BC967-F6D2-4AF5-8B60-528230C4CFF0Q33967026-E04C69C5-D92D-458B-8F73-1BCD4B4ABF28Q34059252-23487ACA-3B9A-4646-BE52-6489C8F8B553Q34156628-9C9A7F55-8A1F-418C-9A51-C4850719C964Q34265282-BFBCC41C-BC06-45C6-B3FB-046800CEE836Q34294843-8651F01D-3AB9-445E-BF72-1D9CE9A1EE45Q34299326-998FC8E9-61EE-469D-80E9-9FF57724898EQ34301906-CFF64942-2715-4BE8-965F-39A85BAFB83BQ34341007-712F4E54-BC00-4285-84EE-FD547CAB3459Q34345031-B50B33E7-B212-49FB-A960-770DC3900D8F
P2860
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
@en
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
@nl
type
label
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
@en
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
@nl
prefLabel
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
@en
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
@nl
P2093
P2860
P356
P1476
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
@en
P2093
P2860
P304
10990-10995
P356
10.1073/PNAS.93.20.10990
P407
P577
1996-10-01T00:00:00Z